Search - tctmd.com

Displaying 121 - 140 of 506

Sort: Relevancy | Date

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Industry News

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

May 24, 2018

News Daily News

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Yael L. Maxwell

May 21, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Industry News

Micell Technologies Announces Expanded Patent Estate - Issued Key Patents Significantly Strengthen Company’s Proprietary Rights in Surface Modification and Controlled Drug Delivery

March 21, 2018

News Conference News ACC 2018

Thin Struts and ‘Pro-Healing’ Layer: COMBO Stent Sees Success at 1 Year

Yael L. Maxwell

March 11, 2018

News Conference News ACC 2018

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Michael O'Riordan

March 11, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Industry News

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

February 26, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

Presentation JIM 2018

The Elixir DynamX Program: A "Novel" Metallic DES with Adaptive Remodeling

Presenter: Martin B. Leon

February 23, 2018

Advertisement

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Uncomplicated TLR After PCI Linked With Worse Mortality

Micell Technologies Announces Expanded Patent Estate - Issued Key Patents Significantly Strengthen Company’s Proprietary Rights in Surface Modification and Controlled Drug Delivery

Thin Struts and ‘Pro-Healing’ Layer: COMBO Stent Sees Success at 1 Year

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

The Elixir DynamX Program: A "Novel" Metallic DES with Adaptive Remodeling

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content